A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia

Angiitis‐induced critical limb ischemia (AICLI) patients constitute a remarkable proportion of no‐option critical limb ischemia (CLI) patients. Stem cell therapy has become an innovative and promising option for no‐option CLI patients. As one of these promising stem cell therapies, purified CD34+ ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yuan, Wei, Zheng, Chen, Bin, Pan, Tianyue, Gu, Shiyang, Liu, Peng, Guo, Daqiao, Xu, Xin, Jiang, Junhao, Yang, Jue, Shi, Zhenyu, Zhu, Ting, Shi, Yun, Liu, Yifan, Dong, Zhihui, Fu, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090512/
https://www.ncbi.nlm.nih.gov/pubmed/29709112
http://dx.doi.org/10.1002/sctm.17-0252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090512/
https://www.ncbi.nlm.nih.gov/pubmed/29709112
http://dx.doi.org/10.1002/sctm.17-0252

Ejemplares similares